Maximus, Inc. $MMS Stock Holdings Lowered by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 27.2% in the 4th quarter, Holdings Channel reports. The fund owned 35,994 shares of the health services provider’s stock after selling 13,449 shares during the period. New Age Alpha Advisors LLC’s holdings in Maximus were worth $3,107,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of MMS. Boston Partners grew its position in shares of Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after acquiring an additional 308,892 shares during the last quarter. UBS Group AG grew its position in shares of Maximus by 76.8% during the fourth quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock worth $52,686,000 after acquiring an additional 265,095 shares during the last quarter. Qube Research & Technologies Ltd grew its position in shares of Maximus by 115.8% during the second quarter. Qube Research & Technologies Ltd now owns 379,342 shares of the health services provider’s stock worth $26,630,000 after acquiring an additional 203,521 shares during the last quarter. Assenagon Asset Management S.A. bought a new position in shares of Maximus during the fourth quarter worth about $15,673,000. Finally, Two Sigma Investments LP bought a new position in shares of Maximus during the third quarter worth about $15,397,000. Institutional investors own 97.21% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Weiss Ratings lowered shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Finally, Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Maximus Stock Down 0.3%

Maximus stock opened at $61.01 on Wednesday. The stock has a market cap of $3.21 billion, a price-to-earnings ratio of 9.13 and a beta of 0.60. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The company’s 50-day moving average price is $65.03 and its two-hundred day moving average price is $77.73. Maximus, Inc. has a 52 week low of $56.92 and a 52 week high of $100.00.

Maximus (NYSE:MMS) last released its earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. Maximus had a net margin of 7.02% and a return on equity of 25.10%. Maximus’s quarterly revenue was down 4.1% on a year-over-year basis. During the same quarter last year, the company earned $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts expect that Maximus, Inc. will post 8.4 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.2%. Maximus’s dividend payout ratio (DPR) is presently 19.76%.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.80% of the company’s stock.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.